1. Home
  2. GDTC vs ISDR Comparison

GDTC vs ISDR Comparison

Compare GDTC & ISDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • ISDR
  • Stock Information
  • Founded
  • GDTC 2018
  • ISDR 1988
  • Country
  • GDTC Singapore
  • ISDR United States
  • Employees
  • GDTC N/A
  • ISDR N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • ISDR Publishing
  • Sector
  • GDTC Health Care
  • ISDR Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • ISDR Nasdaq
  • Market Cap
  • GDTC 33.4M
  • ISDR 35.0M
  • IPO Year
  • GDTC 2023
  • ISDR N/A
  • Fundamental
  • Price
  • GDTC $2.38
  • ISDR $9.30
  • Analyst Decision
  • GDTC Buy
  • ISDR
  • Analyst Count
  • GDTC 1
  • ISDR 0
  • Target Price
  • GDTC $5.00
  • ISDR N/A
  • AVG Volume (30 Days)
  • GDTC 597.0K
  • ISDR 15.0K
  • Earning Date
  • GDTC 01-01-0001
  • ISDR 03-06-2025
  • Dividend Yield
  • GDTC N/A
  • ISDR N/A
  • EPS Growth
  • GDTC N/A
  • ISDR N/A
  • EPS
  • GDTC N/A
  • ISDR N/A
  • Revenue
  • GDTC $330,254.00
  • ISDR $29,141,000.00
  • Revenue This Year
  • GDTC $14.71
  • ISDR N/A
  • Revenue Next Year
  • GDTC N/A
  • ISDR N/A
  • P/E Ratio
  • GDTC N/A
  • ISDR N/A
  • Revenue Growth
  • GDTC N/A
  • ISDR N/A
  • 52 Week Low
  • GDTC $1.20
  • ISDR $7.61
  • 52 Week High
  • GDTC $4.30
  • ISDR $16.92
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 44.91
  • ISDR 53.39
  • Support Level
  • GDTC $2.12
  • ISDR $8.26
  • Resistance Level
  • GDTC $2.64
  • ISDR $8.89
  • Average True Range (ATR)
  • GDTC 0.48
  • ISDR 0.49
  • MACD
  • GDTC -0.10
  • ISDR 0.06
  • Stochastic Oscillator
  • GDTC 13.47
  • ISDR 78.79

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About ISDR Issuer Direct Corporation

Issuer Direct Corp is a communications and compliance company. It focuses on the needs of corporate issuers. It provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. Its customers include public and private companies, mutual funds, law firms, brokerage firms, investment banks, individuals, and other institutions. Its products include PR solutions, IR solutions, Compliance, and Event management software.

Share on Social Networks: